Benzinga | Jul 14, 2021 07:32AM EDT

Asensus Surgical Files For FDA Nod For Additional Capabilities Of Laparoscopy System

* Asensus Surgical Inc (NYSE:ASXC) has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit (ISU).

* The ISU is used on the Company's Senhance Surgical System, which enables digital laparoscopy.

* The current features of the ISU enable machine vision-driven control of the camera for a surgeon. The new features would expand to include more advanced features to gather real-time data during surgery based on the anatomical structures in the surgical field.

* Price Action: ASXC shares are up 5. 3% at $2.59 during the premarket session on the last check Wednesday.

* Related content: Benzinga's Full FDA Calendar.